Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001564821 | SCV001788045 | pathogenic | not provided | 2025-01-21 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 19293843, 12938084, 17657824) |
Labcorp Genetics |
RCV002570752 | SCV003302331 | pathogenic | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-02-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile766Leufs*6) in the FBN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FBN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1199957). For these reasons, this variant has been classified as Pathogenic. |